B12 Injections for Weight Loss: Side Effects You Should Know About

Step 1: Understanding what B12 injections are and why people use them for weight loss

Hydroxocobalamin and cyanocobalamin are the two forms of vitamin B12 given by injection in clinical practice. On the NHS they are used to treat pernicious anaemia and other confirmed B12 deficiency states, delivered intramuscularly into the upper arm or buttock by a healthcare professional. That is their licensed, evidence-based role.

The weight-loss claim attached to B12 injections is a different proposition. The theory goes that correcting a deficiency restores energy metabolism, reducing fatigue and helping people move more. There is something to that — genuine B12 deficiency does cause fatigue and, once corrected, energy improves. But if your B12 level is already normal, injecting more does not accelerate fat loss. The NHS's own guidance on vitamin B12 is clear that supplementation beyond correcting deficiency has no established metabolic benefit. Excess B12 is water-soluble; the body excretes what it cannot use.

That gap between the marketing and the mechanism matters because people chasing a result that the injection cannot reliably produce are still exposed to its real side effects, and our page on the side effects of vitamin B12 injections used for weight loss goes into those in detail. Understanding those is the first step to making a properly informed decision about what injectable options actually exist in the UK for weight management.

Step 2: The side effects reported with B12 injections, from mild to serious

Most people who receive intramuscular B12 injections notice something at the injection site: a patch of redness, localised tenderness or a small firm lump that settles within a day or two. Rotating the injection site reduces but does not eliminate this. Mild nausea and headache are also reported, particularly in the first session.

Less common side effects documented in the clinical literature include acne-like skin eruptions, which appear more frequently with hydroxocobalamin than with cyanocobalamin and tend to resolve after the course ends. Some people notice a transient pink or red flush to the skin. These are generally not dangerous, but they are real and worth knowing about before you start.

The serious end of the spectrum is rare but requires clear-headed treatment. Allergic reactions to cobalt, which B12 contains, can escalate quickly. Anaphylaxis (difficulty breathing, swelling of the throat or tongue, a sudden drop in blood pressure) is uncommon but has been reported; this is a 999 situation, not a wait-and-see one. The NHS patient information on B12 medicines lists these risks in plain terms. For a broader picture of how injection-related side effects compare across different injectable treatments, our page on side effects of weight-loss injections covers the landscape in more detail.

Polycythaemia (a rise in red blood cell mass) is a theoretical concern with very high ongoing doses, most relevant in people with certain blood disorders. For the vast majority of people receiving short courses this is not a practical risk, but it underlines that even a water-soluble vitamin given by injection bypasses the gut's natural absorption limits.

Step 3: When to get medical help, and how to report a reaction

Most injection-site soreness and mild nausea do not need urgent attention. These are the body adjusting to an intramuscular injection, and they pass. Drink water, rest, and monitor.

Call 999 or go to A&E if you notice any of the following after a B12 injection: difficulty breathing or swallowing, swelling of the face, lips or throat, rapid heartbeat with dizziness, or a widespread skin reaction that comes on quickly. These are signs of anaphylaxis and cannot wait.

Contact your GP or 111 within the same day for: severe or worsening pain at the injection site rather than easing, unusual swelling that spreads beyond the injection area, signs of infection (warmth, pus, fever), or any skin rash that does not resolve within 48 hours. Persistent headache after a session is also worth mentioning to a clinician rather than ignoring.

Suspected adverse reactions to any medicine (including vitamins given by injection) can and should be reported. The MHRA's Yellow Card scheme accepts reports from patients directly; it does not need to go through a doctor first. Reporting helps build the evidence base and can flag previously unrecognised patterns. It takes about ten minutes.

Our prescribers regularly discuss injection-related side effects as part of consultations, it is one of those things patients tell us they wished they had been asked about earlier. If you have questions about side effects before starting any injectable treatment, speaking to our prescribers is straightforward and the consultation is free.

Step 4: What is actually licensed for weight loss in the UK, and what that means for safety

If you are researching B12 injections because you want help with weight management, it is worth knowing that the two medicines licensed in the UK specifically for that purpose work on a different mechanism entirely. Tirzepatide (Mounjaro) and semaglutide (Wegovy) are GLP-1-class injectable medicines that act on appetite-regulating receptors in the brain and slow gastric emptying. Their weight-loss effects are documented in large, published trials and reviewed by NICE. Both are prescription-only medicines assessed by a prescriber individually before being supplied.

Their side effect profile is different from B12. Gastrointestinal symptoms (nausea, loose stools, constipation) are the most common, typically at their peak around a dose change and settling with time. That is a distinct picture from B12's injection-site and skin reactions, and if you want to understand whether those reactions tip into something more serious, our page on the bad side effects of weight loss injections sets out what to watch for. For a fuller account of what those side effects feel like in practice, our page on whether weight-loss injections make you feel sick is a useful starting point.

NICE's appraisal of tirzepatide, TA1026, sets out which adults in England meet the criteria for treatment on the NHS and what evidence underpins those recommendations. At nume, a named GPhC-registered prescriber reviews every consultation before any medicine is dispensed, no algorithms, no automated approvals, no shortcuts. If you are weighing up what is right for your situation, our page covering whether weight loss injections have side effects is worth reading alongside a conversation with our clinical team, who are there to work through it with you.